Iijima H - Search Results

1

Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.

Iijima H, Shimizu H, Mori-Anai K, Kawaguchi A, Mochida Y, Yamauchi T, Kadowaki T. Iijima H, et al. Diabetes Ther. 2024 Apr;15(4):779-780. doi: 10.1007/s13300-024-01548-z. Diabetes Ther. 2024. PMID: 38421560 Free PMC article. No abstract available.

2

Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.

Iijima H, Shimizu H, Mori-Anai K, Kawaguchi A, Mochida Y, Yamauchi T, Kadowaki T. Iijima H, et al. Diabetes Ther. 2024 Apr;15(4):763-777. doi: 10.1007/s13300-023-01514-1. Epub 2023 Dec 20. Diabetes Ther. 2024. PMID: 38117459 Free PMC article.

3

Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Watanabe Y, Gouda M, Iijima H. Kadowaki T, et al. Among authors: iijima h. Diabetes Obes Metab. 2018 Jan;20(1):77-84. doi: 10.1111/dom.13038. Epub 2017 Jul 31. Diabetes Obes Metab. 2018. PMID: 28608617 Free PMC article.

4

Renal outcomes with sodium-glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases.

Iijima H, Gouda M, Hida H, Mori-Anai K, Takahashi A, Minai R, Ninomiya H, Saito Y, Miyawaki A, Wada J. Iijima H, et al. Diabetes Obes Metab. 2024 May;26(5):1615-1623. doi: 10.1111/dom.15461. Epub 2024 Feb 27. Diabetes Obes Metab. 2024. PMID: 38413384

5

Safety and efficacy of teneligliptin in Japanese patients with type 2 diabetes mellitus: a pooled analysis of two Phase III clinical studies.

Kadowaki T, Marubayashi F, Yokota S, Katoh M, Iijima H. Kadowaki T, et al. Among authors: iijima h. Expert Opin Pharmacother. 2015 May;16(7):971-81. doi: 10.1517/14656566.2015.1032249. Epub 2015 Apr 10. Expert Opin Pharmacother. 2015. PMID: 25861982

6

Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Iijima H, Watanabe Y, Gouda M. Kadowaki T, et al. Among authors: iijima h. Diabetes Obes Metab. 2017 Jun;19(6):874-882. doi: 10.1111/dom.12898. Epub 2017 Mar 31. Diabetes Obes Metab. 2017. PMID: 28177187 Free PMC article. Clinical Trial.

7

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Gouda M, Iijima H, Watanabe Y. Kadowaki T, et al. Among authors: iijima h. Diabetes Obes Metab. 2018 Feb;20(2):453-457. doi: 10.1111/dom.13079. Epub 2017 Sep 15. Diabetes Obes Metab. 2018. PMID: 28786530 Free PMC article. Clinical Trial.

8

Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus.

Kadowaki T, Haneda M, Ito H, Ueno M, Matsukawa M, Yamakura T, Sasaki K, Kimura M, Iijima H. Kadowaki T, et al. Among authors: iijima h. Expert Opin Pharmacother. 2018 Feb;19(2):83-91. doi: 10.1080/14656566.2017.1420165. Epub 2018 Jan 19. Expert Opin Pharmacother. 2018. PMID: 29268035

9

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus.

Iijima H, Kifuji T, Maruyama N, Inagaki N. Iijima H, et al. Adv Ther. 2015 Aug;32(8):768-82. doi: 10.1007/s12325-015-0234-0. Epub 2015 Aug 18. Adv Ther. 2015. PMID: 26280756 Free PMC article. Clinical Trial.

10

Association between glycemic control and cardiovascular events in older Japanese adults with diabetes mellitus: An analysis of the Japanese medical administrative database.

Yokote K, Suzuki R, Gouda M, Iijima H, Yamazaki A, Inagaki M. Yokote K, et al. Among authors: iijima h. J Diabetes Investig. 2021 Nov;12(11):2036-2045. doi: 10.1111/jdi.13575. Epub 2021 Jun 6. J Diabetes Investig. 2021. PMID: 33988907 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,155 results

Search Page